Comprehensive Solutions For Your Vaccine Platforms
Vaccine production, from process development to full-scale GMP-manufacturing, must be efficient, safe, and cost-effective. Learn how our global capabilities can help you achieve these goals for all your modalities/platforms including inactivated/live attenuated vaccines, subunit vaccines, VLP vaccines, viral vector vaccines, pDNA vaccines, mRNA vaccines.
We describe a range of products most commonly used for vaccine process development and manufacturing. Because each vaccine workflow is unique, however, selection of products most appropriate for your specific workflow requires testing and confirmation through MSAT support.
Discover how expertise—empowered by collaboration—can refine and overcome manufacturing challenges in all vaccine modalities/platforms.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.